Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
F-box and WD repeat domain containing 4 pseudogene 1 (FBXW4P1) is a human gene classified as a pseudogene; it does not encode a functional protein. The parent gene family, F-box/WD-40, is involved in protein degradation through ubiquitin-mediated pathways, relevant to developmental processes including limb formation. FBXW4P1 is distinct from the protein-coding FBXW4 gene, which has been associated through duplications and rearrangements with split hand/foot malformation (ectrodactyly), but this pseudogene itself is not a direct disease locus nor an active therapeutic target. Some aliases overlap with protein-coding forms and related pseudogenes, which may lead to confusion in nomenclature. If you require information about the protein-coding FBXW4 gene (not the pseudogene), it may have molecular functions and disease relevance, but FBXW4P1 itself has no established therapeutic, biomarker, or drug interaction data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on F-box and WD repeat domain containing 4 pseudogene 1 (FBXW4P1).